CoChat

Clomipramine concentration and withdrawal symptoms in 10 neonates

Open access
ter Horst, Peter G. J., van der Linde, Susanne, Smit, Jan Pieter, den Boon, Jan, van Lingen, Richard A., Jansman, Frank G. A., De Jong‐van den Berg, Lolkje T. W., Wilffert, Bob · 2012 · British Journal of Clinical Pharmacology
Cited by 29

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Antidepressants are associated with withdrawal symptoms after in utero exposure. • Half‐life of clomipramine in neonates is prolonged compared with that in adults. WHAT THIS STUDY ADDS • We present 10 cases of neonates exposed in utero to clomipramine, with detailed information about withdrawal symptoms and pharmacokinetics. • There is a high and severe complication rate in our cohort regarding the mother and the neonate. AIM After in utero exposure to tricyclic antidepressants, neonatal withdrawal symptoms have been reported with an estimated incidence between 20 and 50%; however, few data are available for clomipramine. This could also be the case for neonatal pharmacokinetic clomipramine parameters and so this study was set up. METHODS Babies exposed to clomipramine in utero were included in an observational study, approved by the local ethics committee, after written informed consent. Withdrawal symptoms were scored at 12, 24 and 48 h after birth using the Finnegan score. Plasma concentrations were determined using an in‐house‐developed, validated liquid chromatography with mass detection (LC‐MSMS) method at 0, 12, 24 and 48 h after birth. RESULTS We found that three of 11 pregnancies were complicated with pre‐eclampsia. Ten neonates were observed for clomipramine withdrawal symptoms. The observed withdrawal symptoms were too short a period of sleep after feeding (6), poor feeding (3), mild to severe tremors (6), hyperactive Moro reflex (3) and respiratory rate >60 breaths min−1. Serious withdrawal reactions, such as tachycardia and cyanosis, were seen. We calculated a half‐life value of 42 ± 16 h for clomipramine in neonates. Only a weak correlation was found between withdrawal reactions and clomipramine plasma concentration or desmethylclomipramine plasma concentration. CONCLUSIONS In neonates, clomipramine is eliminated with a half‐life value of 42 h, compared with 20 h in adults. In two of 10 neonates, tachycardia and cyanosis were seen as serious withdrawal symptoms after maternal use of clomipramine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2011.04072.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 29

Metadata

Authors
ter Horst, P. G. J., van der Linde, S., Smit, J. P., den Boon, J., van Lingen, R. A., Jansman, F. G. A., De Jong‐van den Berg, L. T. W., & Wilffert, B.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2012-01-06
Volume
73
Issue
2
Pages
295-302
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2167189410
Cited by
29
References
4
FWCI
2.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clomipramine concentration and withdrawal symptoms in 10 neonates. https://app.cochat.ai/papers/10.1111/j.1365-2125.2011.04072.x
The paper
ter Horst, P. G. J., van der Linde, S., Smit, J. P., den Boon, J., van Lingen, R. A., Jansman, F. G. A., De Jong‐van den Berg, L. T. W., & Wilffert, B. (2012). Clomipramine concentration and withdrawal symptoms in 10 neonates. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2011.04072.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.